Experimentation with Strategy and the Evolution of Dynamic Capability in the Indian Pharmaceutical Sector
Suma Athreye (),
Dinar Kale () and
Shyama V. Ramani ()
Additional contact information Dinar Kale: Open University, and ESRC Innogen
Shyama V. Ramani: Institut National de la Recherche Agronomique (INRA), and Ecole Polytechnique Paris
Abstract:
This paper demonstrates that radical regulatory changes can be tantamount to technological revolutions by studying Indian pharmaceutical firms. It shows that radical regulatory changes such as the Indian Patent Act of 1970, the New Industrial Policy of 1991 and the signing of TRIPS (Trade Related Intellectual Property Rights System) in 1995 served to open up new economic opportunities and constraints in the wake of which the winners and losers were selected as a function of the dynamic firm capabilities most appropriate for the new market environment.